If youre researching NAD+ therapy in Chicago, youve probably noticed there are three main ways to get it: IV infusions, subcutaneous injections, and nasal spray
subsequent to a 2011 inspection which found a number of the company's products contained prescription and investigational drugs and were misbranded
With 99%+ purity guaranteed, industry-leading compliance, and a customer-first approach, were setting a new benchmark for peptide excellence
[1] If a rash or generalized itching develops, the injection should be halted and the patient evaluated, as it could be a prodrome of a more serious reaction
Do not rush this step
The FDA issued a warning letter in 2023 regarding companies marketing BPC-157 with therapeutic claims, reinforcing that this peptide lacks the evidence base required for approved drug status [2]